Establishment of reference values for endocrine tests. I: Cushing's syndrome. 1998

M J de Bos Kuil, and E Endert, and E Fliers, and M F Prummel, and J A Romijn, and W M Wiersinga
Department of Endocrinology and Metabolism, Academic Medical Center of the University of Amsterdam, The Netherlands.

BACKGROUND For diagnostic tests used in the evaluation of patients with Cushing's syndrome, well defined reference values were lacking in our laboratory. In the present study, we established reference values based upon test results of 50 subjects recruited from the general population. METHODS We studied 50 subjects not suspected of having Cushing's syndrome, equally distributed according to sex and age between 20 and 69 years. In addition to 24 h urinary excretion of free cortisol for two days, a low-dose (1 mg) overnight dexamethasone suppression test, a corticotropin releasing hormone stimulation test (CRH test) and a high-dose (7 mg) intravenous dexamethasone suppression test were performed. Reference values are given as the observed range. RESULTS There was considerable intra-subject variation in 24 h urinary cortisol excretion which could not be merely attributed to incompleteness of the urine collection. The following reference values were established: 24 h urinary free cortisol excretion: 15-145 nmol/24 h; overnight dexamethasone suppression test: cortisol on day 2 < 50-230 nmol/l; CRH test: cortisol increase 15-289%, ACTH increase 36-12.100%; high-dose, intravenous dexamethasone suppression test: cortisol after 7 h < 50-97 nmol/l; cortisol after 24 h < 50-50 nmol/l. There were no significant effects of age on any of the parameters studied. Apart from higher basal ACTH plasma concentrations in men, no sex differences were observed. CONCLUSIONS We established reference values for tests that can be useful in the evaluation of patients with possible Cushing's syndrome.

UI MeSH Term Description Entries
D007262 Infusions, Intravenous The long-term (minutes to hours) administration of a fluid into the vein through venipuncture, either by letting the fluid flow by gravity or by pumping it. Drip Infusions,Intravenous Drip,Intravenous Infusions,Drip Infusion,Drip, Intravenous,Infusion, Drip,Infusion, Intravenous,Infusions, Drip,Intravenous Infusion
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D012016 Reference Values The range or frequency distribution of a measurement in a population (of organisms, organs or things) that has not been selected for the presence of disease or abnormality. Normal Range,Normal Values,Reference Ranges,Normal Ranges,Normal Value,Range, Normal,Range, Reference,Ranges, Normal,Ranges, Reference,Reference Range,Reference Value,Value, Normal,Value, Reference,Values, Normal,Values, Reference
D003346 Corticotropin-Releasing Hormone A peptide of about 41 amino acids that stimulates the release of ADRENOCORTICOTROPIC HORMONE. CRH is synthesized by neurons in the PARAVENTRICULAR NUCLEUS of the HYPOTHALAMUS. After being released into the pituitary portal circulation, CRH stimulates the release of ACTH from the PITUITARY GLAND. CRH can also be synthesized in other tissues, such as PLACENTA; ADRENAL MEDULLA; and TESTIS. ACTH-Releasing Hormone,CRF-41,Corticotropin-Releasing Factor,Corticotropin-Releasing Hormone-41,ACTH-Releasing Factor,CRF (ACTH),Corticoliberin,Corticotropin-Releasing Factor-41,ACTH Releasing Factor,ACTH Releasing Hormone,Corticotropin Releasing Factor,Corticotropin Releasing Factor 41,Corticotropin Releasing Hormone,Corticotropin Releasing Hormone 41
D003480 Cushing Syndrome A condition caused by prolonged exposure to excess levels of cortisol (HYDROCORTISONE) or other GLUCOCORTICOIDS from endogenous or exogenous sources. It is characterized by upper body OBESITY; OSTEOPOROSIS; HYPERTENSION; DIABETES MELLITUS; HIRSUTISM; AMENORRHEA; and excess body fluid. Endogenous Cushing syndrome or spontaneous hypercortisolism is divided into two groups, those due to an excess of ADRENOCORTICOTROPIN and those that are ACTH-independent. Cushing's Syndrome,Hypercortisolism,Syndrome, Cushing,Syndrome, Cushing's
D003907 Dexamethasone An anti-inflammatory 9-fluoro-glucocorticoid. Hexadecadrol,Decaject,Decaject-L.A.,Decameth,Decaspray,Dexasone,Dexpak,Hexadrol,Maxidex,Methylfluorprednisolone,Millicorten,Oradexon,Decaject L.A.
D003940 Diagnostic Techniques, Endocrine Methods and procedures for the diagnosis of diseases or dysfunction of the endocrine glands or demonstration of their physiological processes. Diagnostic Technic, Endocrine,Diagnostic Technics, Endocrine,Diagnostic Technique, Endocrine,Endocrine Diagnostic Technic,Endocrine Diagnostic Technics,Endocrine Diagnostic Technique,Endocrine Diagnostic Techniques,Technic, Endocrine Diagnostic,Technics, Endocrine Diagnostic,Technique, Endocrine Diagnostic,Techniques, Endocrine Diagnostic
D005260 Female Females
D005938 Glucocorticoids A group of CORTICOSTEROIDS that affect carbohydrate metabolism (GLUCONEOGENESIS, liver glycogen deposition, elevation of BLOOD SUGAR), inhibit ADRENOCORTICOTROPIC HORMONE secretion, and possess pronounced anti-inflammatory activity. They also play a role in fat and protein metabolism, maintenance of arterial blood pressure, alteration of the connective tissue response to injury, reduction in the number of circulating lymphocytes, and functioning of the central nervous system. Glucocorticoid,Glucocorticoid Effect,Glucorticoid Effects,Effect, Glucocorticoid,Effects, Glucorticoid

Related Publications

M J de Bos Kuil, and E Endert, and E Fliers, and M F Prummel, and J A Romijn, and W M Wiersinga
August 1999, The Netherlands journal of medicine,
M J de Bos Kuil, and E Endert, and E Fliers, and M F Prummel, and J A Romijn, and W M Wiersinga
January 2006, The Netherlands journal of medicine,
M J de Bos Kuil, and E Endert, and E Fliers, and M F Prummel, and J A Romijn, and W M Wiersinga
February 2003, The Netherlands journal of medicine,
M J de Bos Kuil, and E Endert, and E Fliers, and M F Prummel, and J A Romijn, and W M Wiersinga
December 2005, The Netherlands journal of medicine,
M J de Bos Kuil, and E Endert, and E Fliers, and M F Prummel, and J A Romijn, and W M Wiersinga
April 2009, The Netherlands journal of medicine,
M J de Bos Kuil, and E Endert, and E Fliers, and M F Prummel, and J A Romijn, and W M Wiersinga
February 1979, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
M J de Bos Kuil, and E Endert, and E Fliers, and M F Prummel, and J A Romijn, and W M Wiersinga
June 1999, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas,
M J de Bos Kuil, and E Endert, and E Fliers, and M F Prummel, and J A Romijn, and W M Wiersinga
February 2003, The Netherlands journal of medicine,
M J de Bos Kuil, and E Endert, and E Fliers, and M F Prummel, and J A Romijn, and W M Wiersinga
December 1990, Clinical endocrinology,
M J de Bos Kuil, and E Endert, and E Fliers, and M F Prummel, and J A Romijn, and W M Wiersinga
September 2002, Annals of the New York Academy of Sciences,
Copied contents to your clipboard!